Item 8.01 Other Events.

On June 9, 2022, Tempest Therapeutics, Inc. (the "Company") issued a press release entitled "Tempest Provides ASCO KOL Feedback on TPST-1120 Clinical Results and Updated Financial Guidance." A copy of the press release is filed as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.

Item 9.01 Financial Statements and Exhibits.




(d) Exhibits

Exhibit
  No.       Description

99.1          Press Release, dated June 9, 2022

104         Cover Page Interactive Data File (embedded within the Inline XBRL document)

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses